Stockscreener 앱 받기
7.46
2.47%
0.18
시장 영업 전:
7.44
-0.02
-0.27%
전일 마감가:
$7.28
열려 있는:
$7.31
하루 거래량:
3.68M
Relative Volume:
0.68
시가총액:
$1.94B
수익:
$6.28B
순이익/손실:
$700.00M
주가수익비율:
2.771
EPS:
2.6922
순현금흐름:
$537.00M
1주 성능:
-2.99%
1개월 성능:
-14.84%
6개월 성능:
-19.61%
1년 성능:
-51.81%
1일 변동 폭
$7.25
$7.5489
1주일 범위
$6.50
$7.58
52주 변동 폭
$6.18
$16.18
오가논 & Co Stock (OGN) Company Profile
명칭
Organon Co
전화
551-430-6000
주소
30 HUDSON STREET, JERSEY CITY
Compare OGN vs LLY, JNJ, ABBV, AZN, NVS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
7.46 | 1.89B | 6.28B | 700.00M | 537.00M | 2.6922 |
|
LLY
Lilly Eli Co
|
1,020.56 | 977.37B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
244.99 | 586.40B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
228.72 | 411.55B | 61.16B | 4.20B | 19.68B | 2.3671 |
|
AZN
Astrazeneca Plc
|
208.67 | 324.75B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
165.38 | 317.08B | 54.72B | 14.02B | 15.32B | 7.1855 |
오가논 & Co Stock (OGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Underweight |
| 2025-10-27 | 다운그레이드 | Piper Sandler | Overweight → Underweight |
| 2025-05-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-09-06 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-11-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-09-21 | 개시 | Barclays | Overweight |
| 2023-03-16 | 개시 | Raymond James | Outperform |
| 2022-10-14 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-09-06 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-10-07 | 개시 | Piper Sandler | Neutral |
| 2021-09-01 | 개시 | BofA Securities | Buy |
| 2021-07-22 | 개시 | Citigroup | Buy |
| 2021-06-15 | 개시 | JP Morgan | Neutral |
| 2021-06-11 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-06-10 | 개시 | Evercore ISI | Outperform |
모두보기
오가논 & Co 주식(OGN)의 최신 뉴스
5 Revealing Analyst Questions From Organon’s Q4 Earnings Call - Yahoo Finance UK
Organon & Co. (OGN) Stock Analysis: Evaluating a Potential 24.69% Upside in the Healthcare Sector - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Organon & Co. (OGN) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Trading Systems Reacting to (OGN) Volatility - Stock Traders Daily
Organon (OGN) Is Down 10.0% After Earnings Miss And Cautious 2026 OutlookHas The Bull Case Changed? - simplywall.st
Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know - Finviz
BofA Securities Maintains Organon & Co(OGN.US) With Sell Rating - 富途牛牛
Organon (OGN) Is Down 12.8% After Earnings Miss And Flat 2026 Outlook Has The Bull Case Changed? - Yahoo Finance
OGN Q4 Deep Dive: Margin Compression and U.S. Headwinds Shape 2026 Outlook - Finviz
Organon & Co. Plans Quarterly Dividend of $0.02 (NYSE:OGN) - MarketBeat
Organon & Co. (NYSE:OGN) Q4 2025 Earnings Call Transcript - Insider Monkey
Assessing Organon (OGN) Valuation After Earnings Miss And Flat 2026 Revenue Guidance - Yahoo Finance
LSV Asset Management Has $83.67 Million Holdings in Organon & Co. $OGN - MarketBeat
Organon Co earnings missed by $0.13, revenue fell short of estimates - Investing.com South Africa
Organon Reshapes Women’s Health Focus With Nexplanon Shift And Jada Sale - Yahoo Finance
Organon Q4 2025 slides: Revenue declines accelerate, stock tumbles on earnings miss By Investing.com - Investing.com South Africa
Organon Q4 2025 slides: Revenue declines accelerate, stock tumbles on earnings miss - Investing.com Canada
Organon & Co. Q4 Earnings Call Highlights - MarketBeat
Organon (NYSE:OGN) Reports Q4 CY2025 In Line With Expectations - The Globe and Mail
Organon & Co To Go Ex-Dividend On February 23rd, 2026 With 0.02 USD Dividend Per Share - 富途牛牛
Organon Earnings Call Balances Stability With Rising Risks - TipRanks
Organon Q3 Net Margin Squeeze Challenges Bullish Earnings Growth Narratives - simplywall.st
Organon & Co. Q4 2025 Earnings Call Summary - Yahoo Finance
Organon Shares Slide on Quarterly Loss and Cautious Outlook - AD HOC NEWS
Organon (OGN) Q4 2025 Earnings Call Transcript - The Globe and Mail
Organon & Co. (NYSE:OGN) Issues Earnings Results - MarketBeat
Organon: Overview of Fourth Quarter Financial Results - Bitget
Bronstein, Gewirtz & Grossman, LLC Encourages Organon & Co. (OGN) Investors to Inquire about Securities Investigation - ACCESS Newswire
Organon Q4 Earnings ReviewPoor Results Trigger Predictable Sell-Off (NYSE:OGN) - Seeking Alpha
Organon sees FY26 revenue $6.2B, consensus $6.11B - TipRanks
Organon outlines flat $6.2B revenue and $1.9B EBITDA targets for 2026 as cost controls and portfolio shifts take center stage - MSN
Organon reports Q4 adjusted EPS 63c, consensus 73c - TipRanks
Organon Shares Fall After 4Q Earnings Miss Expectations - 富途牛牛
Organon & Co. (NYSE:OGN) Shares Gap Down Following Weak Earnings - MarketBeat
Organon (OGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
OGN: 2025 results show stable revenue and EBITDA, with 2026 guidance flat amid margin and policy headwinds - TradingView
Organon Co earnings missed by $0.13, revenue fell short of estimates By Investing.com - Investing.com Canada
Earnings call transcript: Organon Q4 2025 reveals EPS miss, stock drops 10.8% - Investing.com
Organon (OGN) Misses Q4 Earnings and Revenue Estimates - Yahoo Finance
Organon falls as women’s health unit drives Q4 miss (OGN:NYSE) - Seeking Alpha
Organon: Q4 Earnings Snapshot - kare11.com
Organon Q4 Adjusted Earnings, Revenue Fall; 2026 Revenue Outlook Issued - 富途牛牛
Earnings snapshot: Organon & Co. misses bottom-line estimates; initiates FY26 outlook - MSN
Organon & Co (NYSE:OGN) Shares Drop on Q4 Earnings Miss and Flat 2026 Outlook - ChartMill
(OGN) Organon Expects 2026 Revenue About $6.22B, vs. FactSet Est of $6.11B - marketscreener.com
Earnings Flash (OGN) Organon Posts Q4 Revenue $1.51B, vs. FactSet Est of $1.54B - marketscreener.com
Earnings Flash (OGN) Organon Posts Q4 Adjusted EPS $0.63, vs. FactSet Est of $0.73 - marketscreener.com
Organon shares fall over 5% as Q4 earnings miss expectations By Investing.com - Investing.com South Africa
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025 - Business Wire
오가논 & Co (OGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
1.63%
자본화:
|
볼륨(24시간):